Literature DB >> 20383719

Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.

Thomas Ziebart1, Stefan Walenta, Martin Kunkel, Torsten E Reichert, Wilfried Wagner, Wolfgang Mueller-Klieser.   

Abstract

PURPOSE: A high lactate content in malignant head and neck cancer (Head and neck squamous cell carcinomas, HNSCC) is associated with a higher risk of metastatic spread and lower overall patient survival. However, until present, the underlying mechanisms are not clearly understood. Here, a systematic comparison of glucose metabolism in HNSCC and homologous normal tissue is presented for the first time.
METHODS: The concentrations of glucose, lactate and ATP were measured in cryobiopsies of 29 human HNSCC and of 9 normal mucosa using bioluminescence imaging. The protein expression of lactate dehydrogenase (LDH) was analyzed by Western blotting.
RESULTS: Tumors own a higher content of lactate and LDH in comparison with normal tissues. However, within the tumor group, the grade of LDH expression shows substantially strong variation and overlap with normal values. Furthermore, LDH expression was not correlated with tumor lactate content. Investigating a small subpopulation, patients with a short-term survival had significantly higher tumor lactate levels compared to patients with long-term survival.
CONCLUSIONS: The data provide clear evidence of an enhanced glycolysis in tumors compared to normal tissue. This may partially but not completely attributable to an elevated expression of LDH. High tumor lactate levels may be predictive for restricted patient survival. In conclusion, lactate measurements, for example non-invasively with MRT, should be advanced for use in clinical routine as a supportive tool for tumor diagnosis and prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383719     DOI: 10.1007/s00432-010-0875-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  Correlation of high lactate levels in head and neck tumors with incidence of metastasis.

Authors:  S Walenta; A Salameh; H Lyng; J F Evensen; M Mitze; E K Rofstad; W Mueller-Klieser
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.

Authors:  Jennifer S Isaacs; Yun Jin Jung; David R Mole; Sunmin Lee; Carlos Torres-Cabala; Yuen-Li Chung; Maria Merino; Jane Trepel; Berton Zbar; Jorge Toro; Peter J Ratcliffe; W Marston Linehan; Len Neckers
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

3.  Mitochondrial impairment in p53-deficient human cancer cells.

Authors:  Shaoyu Zhou; Sushant Kachhap; Keshav K Singh
Journal:  Mutagenesis       Date:  2003-05       Impact factor: 3.000

Review 4.  Microenvironment-induced cancer metastasis.

Authors:  E K Rofstad
Journal:  Int J Radiat Biol       Date:  2000-05       Impact factor: 2.694

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 6.  Lactate: mirror and motor of tumor malignancy.

Authors:  Stefan Walenta; Wolfgang F Mueller-Klieser
Journal:  Semin Radiat Oncol       Date:  2004-07       Impact factor: 5.934

Review 7.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

8.  EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.

Authors:  Nabendu Pore; Zibin Jiang; Anjali Gupta; George Cerniglia; Gary D Kao; Amit Maity
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

9.  Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.

Authors:  Jian Chen; Songji Zhao; Kunihiro Nakada; Yuji Kuge; Nagara Tamaki; Futoshi Okada; Jingxin Wang; Masanobu Shindo; Fumihiro Higashino; Kohji Takeda; Masahiro Asaka; Hiroyuki Katoh; Toshio Sugiyama; Masuo Hosokawa; Masanobu Kobayashi
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; G Bougioukas; V Didilis; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

View more
  24 in total

1.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

2.  Comparative metabolic analysis in head and neck cancer and the normal gingiva.

Authors:  Nadine Fabienne Voelxen; Sebastian Blatt; Pascal Knopf; Maurice Henkel; Christina Appelhans; Leonardo A R Righesso; Andreas Pabst; Jutta Goldschmitt; Stefan Walenta; Andreas Neff; Wolfgang Mueller-Klieser; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2017-07-22       Impact factor: 3.573

Review 3.  Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?

Authors:  Gabriele Grasmann; Elisabeth Smolle; Horst Olschewski; Katharina Leithner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

4.  HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer.

Authors:  Richard A Burkhart; Danielle M Pineda; Saswati N Chand; Carmella Romeo; Eric R Londin; Edward D Karoly; Joseph A Cozzitorto; Isidore Rigoutsos; Charles J Yeo; Jonathan R Brody; Jordan M Winter
Journal:  RNA Biol       Date:  2013-06-13       Impact factor: 4.652

5.  Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.

Authors:  Sebastian Blatt; Nadine Voelxen; Keyvan Sagheb; Andreas Max Pabst; Stefan Walenta; Thies Schroeder; Wolfgang Mueller-Klieser; Thomas Ziebart
Journal:  Clin Oral Investig       Date:  2016-01-04       Impact factor: 3.573

6.  Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues.

Authors:  Bagganahalli S Somashekar; Pachiyappan Kamarajan; Theodora Danciu; Yvonne L Kapila; Arul M Chinnaiyan; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  J Proteome Res       Date:  2011-10-18       Impact factor: 4.466

Review 7.  Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets.

Authors:  Vlad C Sandulache; Jeffrey N Myers
Journal:  Head Neck       Date:  2011-02-14       Impact factor: 3.147

8.  Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study.

Authors:  Marco Johannes Battista; Kristina Goetze; Marcus Schmidt; Cristina Cotarelo; Veronika Weyer-Elberich; Annette Hasenburg; Wolfgang Mueller-Klieser; Stefan Walenta
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-24       Impact factor: 4.553

9.  Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer.

Authors:  Melissa N Loja; Zhen Luo; D Greg Farwell; Quang C Luu; Paul J Donald; Deborah Amott; Anh Q Truong; Regina F Gandour-Edwards; N Nitin
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

10.  Significance of endothelial progenitor cells (EPC) for tumorigenesis of head and neck squamous cell carcinoma (HNSCC): possible marker of tumor progression and neovascularization?

Authors:  Thomas Ziebart; Sebastian Blatt; Christian Günther; Nadine Völxen; Andreas Pabst; Keyvan Sagheb; Sebastian Kühl; Thomas Lambrecht
Journal:  Clin Oral Investig       Date:  2016-03-19       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.